A synthetic peptide for use as a blocking control in assays to test for specificity of ASPA antibody, Alternative Names: ASPA control peptide, ASPA antibody Blocking Peptide, Anti-ASPA Blocking Peptide, Aspartoacylase Blocking Peptide, Canavan Disease Blocking Peptide, ACY2 Blocking Peptide, ASP Blocking Peptide
ASPA catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids.